Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

CORRECTION: BiomX Q3 EPS $(0.23) Up From $(0.37) YoY

BiomX (AMEX:PHGE) reported quarterly losses of $(0.23) per share. This is a 37.84 percent increase over losses of $(0.37) per share from the same period last year.
byBenzinga Newsdesk
November 9, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

BiomX (AMEX:PHGE) reported quarterly losses of $(0.23) per share. This is a 37.84 percent increase over losses of $(0.37) per share from the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Altamira Therapeutics’ Peptide-Based Delivery Platform Shown To Enhance Potency Of Commonly Used Gene Delivery Method Published In The Journal Of Integrative Medicine Titled, “Melittin Analog P5RHH Enhances Recombinant Adeno-Associated Virus Transducti…

By Benzinga Newsdesk
February 7, 9:48 AM
  Independent peer-reviewed study shows enhanced cell transduction with adeno-associated virus (AAV) vectors, commonly used in gene therapy, when integrating Altamira's peptide-based delivery technology     

CYTO